MTHFR Genetic Polymorphism Screening for Personalized Folic Acid Supplementation

Jul 1, 2020 · 1 min read
projects

Overview

Duration: July 2020 – November 2024

Role: Research Team Member

Project Overview

This project utilized MTHFR genetic polymorphism testing to stratify the risk of neural tube defects in infants, enabling personalized active folate supplementation and lifestyle guidance for pregnant women.

My Contributions

  • Independently developed a patient results query system to improve accessibility of genetic testing outcomes
  • Collaborated with colleagues to secure 2 invention patents

Outcomes

  • Beneficiaries: 17,137+ pregnant women received personalized folate supplementation guidance
  • Patents:
    • Folate Gene and Folic Acid Concentration Determination Sample Preprocessing Device (CN212988971U, April 2021)
    • Cooling Bottle (CN215063055U, December 2021)
Dongxu Wang
Authors
Dongxu Wang (he/him)
Pharmacist | Researcher

Clinical Pharmacist specializing in pharmacy practice and health services research. Currently serving as a Clinical Trial Quality Assurance Officer at Affiliated Women’s Hospital of Jiangnan University (Jiangnan University Affiliated Maternity and Child Healthcare Hospital), and Committee Member & Executive Secretary of the Pharmaceutical Policy Professional Committee, Wuxi Pharmacists Association.

My research focuses on pharmacist competency development, drug information visualization, and patient-centered pharmaceutical care. I led the “Drug Package Insert Reform & Visualization Project” (2020–2025), which developed over 150 visualized medication instruction videos benefiting 850,000+ patients. This work contributed to the establishment of the first batch of Jiangsu Pharmaceutical Association “Pharmacy Science Popularization Base” in April 2024.

Committed to bridging the gap between pharmaceutical science and public health through innovative communication strategies and evidence-based policy research.